CRNX Crinetics Pharmaceuticals, Inc.
Price Chart
Executive Summary
Crinetics Pharmaceuticals announced a future earnings date for Q1 2026 but did not release actual financial results in this press release. The company reiterated its business update and pipeline progress without providing any new financial data for the reported period.
Actionable Insight
Traders should monitor the May 7 earnings call for actual financial performance and potential guidance updates; this release only sets expectations for disclosure timing.
Key Facts
- Crinetics will report Q1 2026 financial results on May 7, 2026, after market close.
- No financial results were released in this announcement — only a schedule for future reporting.
- Management will host a conference call to discuss results and provide a business update.
- The press release emphasizes pipeline progress, including PALSONIFY™ and late-stage candidate atumelnant.
- No financial metrics (revenue, EPS, guidance) were disclosed for Q1 2026 or any prior period in this filing.
Financial Impact
No financial impact from this filing — no results released.
Risk Factors
- Lack of financial disclosure limits near-term trading catalysts.
- Recent insider selling ($651K over 30 days) may signal caution ahead of earnings.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3270499 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 14, 2026
today
|
Press Release
| — | awaiting T+20 | — | — |
|
Jun 14, 2026
today
|
Press Release
| — | awaiting T+20 | — | — |
|
May 7, 2026
5w ago
|
8-K
| $37.48 $32.92 | ▼ −12.17% | ▼ −12.19% | $34.47 (−8.03%) |
|
Apr 10, 2026
9w ago
|
8-K
| $38.66 $36.55 | ▼ −5.46% | ▼ −13.19% | $34.47 (−10.84%) |
|
Apr 8, 2026
9w ago
|
Press Release
| $39.63 $41.71 | ▲ +5.25% | ▼ −2.32% | $34.47 (−13.02%) |
|
Mar 12, 2026
13w ago
|
Insider Cluster
| $36.51 $39.44 | ▼ −8.03% | ▼ −6.05% | $34.47 (+5.59%) |
|
Feb 26, 2026
15w ago
|
8-K
| $41.10 $33.67 | ▼ −18.08% | ▼ −10.52% | $34.47 (−16.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access